Navigation Links
TNI BioTech, Inc., Announces an Extension to the Record Date of its wholly owned subsidiary, Cytocom Inc., and Dividend now Set for September 30, 2014
Date:8/14/2014

up to the 30th of September 2014.

  • Stock settlement dates take up to 3 days; thus a shareholder's name may not be on the Non-Objecting Beneficial Owners List in time. This has confused a lot of shareholders.

  • From August 3 to August 5, 2014, the Company's executives met with Mr. Ye Jige, Chairman and CEO of Hubei Qianjiang Pharmaceutical Co., Ltd. ("Hubei) to discuss and negotiate three agreements between the Company and Hubei.  Also present were scientific and financial advisors to the Company who are not officers and directors of the Company.

    One agreement between the Company and Hubei has been executed and an 8-K filed and two other agreements are being translated into Chinese and are subject to Board Approval by both companies prior to execution.  Each of these agreements holds significance to our future and its long range plans and disclosure will be made by appropriate Securities and Exchange Commission filings on form 8-K; however, since non-public information is available to persons other than our officers or directors and to preclude the possibility of individuals trading on such information or disseminating it to others, we have decided to extend the record date of the Cytocom Inc., stock dividend from August 15, 2014 until September 30, 2014.   This will allow the above-described information on which Company investment decisions might be made available to all shareholders and potential shareholders of the Company and Cytocom Inc.

  • The Ex-Dividend date will be the next trading day, October 1st, 2014.

  • All shareholders are encouraged to have their shares settled before September 30, 2014, which means purchasing the stock on or before September 25, 2014. 
  • About TNI BioTech, Inc.

    We are a biotechnology company working to combat chronic, life-threate
    '/>"/>

    SOURCE TNI BioTech, Inc.
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related biology technology :

    1. Defining Low Cost in Your Solution for Future Facilities, New Webinar for Pharma, Biotech, Medical Device and Healthcare Companies, Hosted by Xtalks
    2. Sandia Biotech, Inc. and Sigma-Aldrich Enter into Global Distribution and Marketing Agreement
    3. TNI BioTech, Inc. Announces Death of Senior Vice President and Chief Medical Officer, Dr. Ronald Herberman
    4. TNI BioTech, Inc. Appoints Industry Veteran, Dr. Joseph Fortunak, as a Strategic Consultant
    5. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of PROLOR Biotech, Inc. in Connection with the Sale of the Company to OPKO Health, Inc.
    6. Law Office of Brodsky & Smith, LLC Announces Investigation of PROLOR Biotech, Inc.
    7. Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech, 2013 Edition
    8. Air Products to Feature Medical and Industrial Grade Gas Solutions for Pharma, Biotech, and Life Science Applications at Mid-Atlantic Bio Conference
    9. RayBiotech, Inc. Achieves Both GMP- and GLP-Compliance and Announces New Dedicated Services Laboratory
    10. RayBiotech, Inc. and the University of Oslo Enter into Antibody Array Services Collaboration
    11. RayBiotech, Inc. Announces New Diagnostic Core Facility Partnering Program
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/30/2015)... ... ... The 2015 Market Research Report on the Global Propanol Industry is ... with a focus on the Chinese situation. Major companies included in the propanol market ... Royal Dutch Shell, LG Chem and Zhejiang Xinhua Chemical. , The report provides a ...
    (Date:7/30/2015)... ... July 30, 2015 , ... Leading regenerative veterinary medicine company, ... canine osteoarthritis stem cell product, currently under development for FDA approval. The product ... marketed in the US by Aratana. This product, termed AT-016, is an allogeneic ...
    (Date:7/30/2015)... , Inc. (NASDAQ: SNMX ), a leading company ... commercialize novel flavor ingredients for the food, beverage, and ... second quarter 2015. "Moving into the ... achieve our commercial and financial goals," stated John Poyhonen, ... our last quarterly earnings report, our two partners have ...
    (Date:7/30/2015)... 2015 Ascendis Pharma A/S (Nasdaq: ... innovative TransCon technology to address significant unmet medical ... six-month Phase 2 study to evaluate the safety ... 53 treatment-naïve, pre-pubertal children with growth hormone deficiency, ... with the top-line results from our Phase 2 ...
    Breaking Biology Technology:Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7
    ... Wis. StrandSoft Inc . announced on ... messaging system that allows businesses to use video ... multiple business opportunities without forcing major system alterations, ... offers, restaurant specials, hospital procedures, and health club ...
    ... A new kind of science is revolutionizing technology, and ... million to harness its potential during the next five ... of materials and processes at scales so small that ... microscope. These materials measure between one and 100 nanometers, ...
    ... about Midwest technology workplaces in this Nine2Five column, ... Midwest tech employee if you work from home doing outside ... technology is so integrated into our daily work lives nowadays ... the "bleep" noise from the machine is finished. , ,So ...
    Cached Biology Technology:Online Kiosks provides a new way to send a message 2UW-Madison gets $13 million to study nanotech 2You might work in a Midwest technology environment if... 2You might work in a Midwest technology environment if... 3
    (Date:7/8/2015)... July 8, 2015  Trovagene, Inc. (NASDAQ: ... today announced the launch of a study that ... Cancer Monitoring℠ (PCM) technology for predicting response to ... a combination of the novel immunotherapy agents Yervoy® ... PD-1 inhibitor. The 50-patient study will be led ...
    (Date:7/7/2015)... 2015  Based on its recent analysis of ... Credence ID, LLC with the 2015 Asia-Pacific ... Year Award. Credence ID has developed a low-cost, ... of offering enrollment and identification solutions to the ... was formed by experts from the mobile biometrics ...
    (Date:7/2/2015)... , June 25, 2015 ... addition of the "Next Generation Biometrics Market by ... 2020" report to their offering. The ... Billion by 2020, at a CAGR of 17.9% between ... the leading application for the market. Safran SA ...
    Breaking Biology News(10 mins):Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3
    ... London, containing more than a dozen skeletons of people ... are thought to have died during the 14th century ... the site. The Plague is by definition ... is highly contagious, leading to mass outbreaks across populations. ...
    ... the Max Planck Institute for Polymer Research (MPI-P) in ... a mineral content of almost 90 percent, yet extremely ... sea sponges and recreated the sponge spicules using the ... sponge. Natural minerals are usually very hard and prickly, ...
    ... living in the Nebraska Sandhills, color can literally be the ... colonized the region, the dark-coated mice stood out starkly against ... Over the next 8,000 years, however, the mice evolved a ... stripe on their tails and changes in the extent of ...
    Cached Biology News:Inspired by deep sea sponges: Creating flexible minerals 2One gene, many mutations 2One gene, many mutations 3
    Chicken Anti-Human DNA-directed RNA Polymerase II 7.6 Kd Polypeptide (POLR2L Polyclonal AntibodyOther Sub-Family: not assigned-Other Applications: ELISA, Western Blot...
    The BD CBA Human Apoptosis Kit can be used to quantitatively measure,cleaved PARP, Bcl-2, and active Caspase-3 protein levels in a single sample. The,Kit performance has been optimized for analysis o...
    ... proteases/caspases initiates apoptosis in mammalian cells. ... provides a simple and convenient means for ... in intact cells. The assay utilizes ... linked to rhodamine 110 (D2R), a reported ...
    The PROTEAN II slab gel casting stand is a component of the PROTEAN II XL and xi casting apparatus. It is supplied with gaskets....
    Biology Products: